All News

E-cigarette use recently doubled among teens, and these teens are also smoking conventional cigarettes.

The message for U.S. pharmacies and pharmacy chains: Follow the lead of CVS Caremark and halt pharmacy tobacco sales.

They shot back: Responses to Goose Rawlings' "They shoot horses, don't they?"

Some basic facts on prediabetes and lifestyle choices that will empower pharmacy patients.

While the big chains compete aggressively for preferred provider status, indies and small chains have a tougher time cutting copays and network prices.

NCPA study finds that community pharmacy med-synch programs can improve patients’ medication adherence and boost the pharmacy's bottom line.

Pharmacists cannot solve the drug abuse problem, but they can refrain from abetting drug-seekers - and give chronic-pain patients the support they deserve.

In the wake of the recent Rite Aid HIV settlement, pharmacists face a new Catch 22.

Don't let the prescriber's hostility stop you from doing the right thing. As the pharmacist, you're the Rx expert.

Unsalable quantities of expensive branded medications and specialty drugs. Skyrocketing prices for generic drugs. Medicaid rules about what to dispense. And there's more.

CMS is proposing a modified interpretation of the existing non-interference provisions that would remove any limitation on CMS’ regulation of the relationship between pharmacies and plan sponsors.

What would you do if you scrambled through that 3.5 hour window, only to find a colleague waiting with his foot stuck out?

Approved in October 2013 for two patient groups, Riociguat (Adempas, Bayer) is a first-in-class sGC stimulator.

Compared to plasma, treatment with 4-factor PCC for warfarin reversal in patients with intracerebral hemorrhage does not seem to reduce 30-day all-cause mortality.

In the pharmacy, an array of foot-care products awaits patients who can't stand it anymore.

This case report underscored the importance of performing accurate genotyping before initiation of therapy.

Pharmacists who collaborate with ACOs can find many ways to exercise their skills and expand their knowledge. Partnerships are popping up everywhere, and so are the opportunities.

ISMP reports that a growing number of cases of oral vaccines intended to protect children against rotavirus gastroenteritis are mistakenly being injected.

Researchers have found a link between women who have taken oral contraceptives and an increased risk of multiple sclerosis (MS). However, this does not mean women should stop taking birth control.

Is your hospital ready? The emergency is here.

Myelita Melton is CEO of SpeakEasy Communications. With the ever-increasing Spanish-speaking population in the United States, Melton says either your pharmacy will find a way to better accommodate this group or your competitors will.

Dr. Reddy’s Laboratories has launched moxifloxacin HCl tablets, 400 mg, a therapeutic equivalent generic version of Avelox on March 4, following FDA approval.

In 2013, physician assistants, nurse practitioners, and others wrote nearly a third of the painkiller prescriptions issued, according to an investigation by the Milwaukee Journal Sentinel and Medpage Today.

Teva Pharmaceutical Industries launched loxapine inhalation powder, 10 mg (Adasuve) March 3, for the acute treatment of agitation associated with schizophrenia or bipolar 1 disorder in adults.

Pharmacy groups, representing more than 100,000 pharmacists in different pharmacy practice settings, have written to CMS Administrator Marilyn B. Tavenner to express their support for the expansion of medication therapy management (MTM) services to Medicare Part D beneficiaries in the CMS proposal released in early January.

The study concludes that AHA and other organizations should add depression to the official list of risk factors for acute coronary syndrome.

Claiming pharmacy benefit managers are trying to run them out of business, more than 100 Oklahoma independent pharmacists recently rallied at their state capitol.

Warfarin use may be safe following a heart attack in patients with both atrial fibrillation and chronic kidney disease, according to a Swedish study of more than 24,000 patients.